Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Safety and Feasibility of Autologous M2 Macrophage Transplantation in Treatment of Non-Acute Stroke Patients

NCT01845350 is registered in ClinicalTrials.gov with Siberian Branch of the Russian Academy of Medical Sciences as lead sponsor.

NCT NCT01845350
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01845350 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Safety and Feasibility of Autologous M2 Macrophage Transplantation in Treatment of Non-Acute Stroke Patients
Lead sponsor
Siberian Branch of the Russian Academy of Medical Sciences
Phase
Phase 1
Overall status
Completed
Start date
October 31, 2012
Completion date
October 31, 2015
Enrollment
13 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hemorrhagic stroke, ischemic stroke